Analyst Conference Summaries

Biotechnology Investor Aids

Bristol-Myers Squibb
RETA

conference date: July 28, 2021 @ 5:00 AM Pacific Time

Bristol Myers Squibb Offers Growth With A Safe Dividend [June 23, 2020] at Seeking Alpha

Bristol-Myers Squibb On Roll With Opdivo Results [October 3, 2019] at Seeking Alpha

I Plan To Keep Bristol-Myers Squibb Stock Issued For Celgene [January 15, 2019] at Seeking Alpha

2021
Bristol-Myers
Squibb
Q4 2020
Bristol-Myers
Squibb
Q1 2021
Bristol-Myers
Squibb
Q2 2021
 
Feb. 4, 2021 April 29, 2021 July 28, 2021  
2020
Bristol-Myers
Squibb
Q4 2019
Bristol-Myers
Squibb
Q1 2020
Bristol-Myers
Squibb
Q2 2020
Bristol-Myers
Squibb
Q3 2020
Feb. 6, 2020 May 7, 2020 Aug. 6, 2020 Nov. 5, 2020
2019
Bristol-Myers
Squibb
Q4 2018
Bristol-Myers
Squibb
Q1 2019
Bristol-Myers
Squibb
Q2 2019
Bristol-Myers
Squibb
Q3 2019
Jan. 24, 2019 April 25, 2019 July 25, 2019 Oct. 31, 2019

Bristol-Myers Squibb (BMY) is a large-cap biotechnology and pharmaceutical company.

Bristol-Myers Squibb web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 ALXN
 AMAT
 AMGN
 APRE
 ARWR
 BIIB
 BMY
 CLDX
 DRNA
 EPZM
 GILD
 GLYC
 ILMN
 INO
 IONS
 ISRG
 MCHP
 MRNA
 PLX
 REGN
 RNA
 SAGE
 SGEN
 TTPH
 VBLT
 VSTM
 XLRN
       

Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2021 William P. Meyers